New Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
On the Frontlines of Prostate CancerNew Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
Why Words Matter: Rethinking Terminology in Advanced Prostate Cancer
On the Frontlines of Prostate CancerWhy Words Matter: Rethinking Terminology in Advanced Prostate Cancer
Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
NeuroFrontiersInnovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Project Oncology®TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Clinician's RoundtableProstate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Improving Conduit and Neobladder Efficiency: Surgical and Post-Operative Strategies
Clinician's RoundtableImproving Conduit and Neobladder Efficiency: Surgical and Post-Operative Strategies
- advertisement
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
CME/CEExpert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
Advancing Care in Non-Clear Cell RCC: Optimizing ICI and TKIs
CME/CEAdvancing Care in Non-Clear Cell RCC: Optimizing ICI and TKIs
Patient-Centric ADT Intensification in Hormone-Sensitive Prostate Cancer: Balancing Efficacy, Safety, Quality of Life, and Survival
CME/CE Broadcast ReplayPatient-Centric ADT Intensification in Hormone-Sensitive Prostate Cancer: Balancing Efficacy, Safety, Quality of Life, and Survival
Antibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
CME/CEAntibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
- advertisement